Professor of Pediatrics, UCLA
Pediatric Nephrology
Dr. Isidro B. Salusky, MD
|
|
Give Review
Dr. Isidro B. Salusky is an expert in the field of Pediatric Nephrology. He received 3 awards: "Top Doctors:LA Area", "Top Doctors:Southern California" and "Super Doctor". Dr. Isidro B. Salusky has written publications. He has 52 publications published with PubMed. The lastest publication is: 'Combining exercise and growth hormone therapy: how can we translate from animal models to chronic kidney disease children?' He is registered with Medicare and accepts Medicare payments.
Publications
- Fracture Burden and Risk Factors in Childhood CKD: Results from the CKiD Cohort Study.
- Combining exercise and growth hormone therapy: how can we translate from animal models to chronic Kidney disease children?
- Effects of Acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients.
- Primary osteoblast-like cells from patients with end-stage Kidney disease reflect gene expression, proliferation, and mineralization characteristics ex vivo.
- Four-dimensional, multiphase, steady-state imaging with contrast enhancement (MUSIC) in the Heart: A feasibility study in children.
- Lack of FGF23 Response to Acute Changes in Serum Calcium and PTH in Humans.
- High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic Kidney disease cohort.
- The role of bone in CKD-mediated mineral and vascular Disease.
- The accuracy of a continuous volumetric balancing system in pediatric continuous Renal replacement therapy.
- Disordered FGF23 and Mineral Metabolism in Children with CKD.
- FGF23 protein expression in coronary arteries is associated with impaired Kidney function.
- Short daily hemodialysis is associated with lower plasma FGF23 levels when compared with conventional hemodialysis.
- FGF23 and mineral Metabolism in the early post-renal transplantation period.
- The Skeletal Consequences of Growth Hormone Therapy in Dialyzed Children: A Randomized Trial.
- Beyond mineral Metabolism, is there an interplay between FGF23 and vitamin D in innate immunity?
- Chronic Kidney disease: mineral and bone disorder in children.
- Phosphate binders, vitamin D and calcimimetics in the management of chronic Kidney disease-mineral bone disorders (CKD-MBD) in children.
- Correlates of parathyroid hormone concentration in hemodialysis patients.
- Association of pre-Kidney transplant markers of mineral and bone disorder with post-transplant outcomes.
- An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects.
- FGF23 inhibits extra-Renal synthesis of 1,25-dihydroxyvitamin D in human monocytes.
- Evaluation of Hypophosphatemia: Lessons From Patients With Genetic Disorders.
- Early Skeletal and Biochemical Alterations in Pediatric Chronic Kidney Disease.
- Mineral abnormalities and long-term graft function in pediatric Renal transplant recipients: a role for FGF-23?
- Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hy...
- Value of the new bone classification system in pediatric Renal osteodystrophy.
- FGF-23: More than a regulator of Renal phosphate handling?
- Reduction of serum hepcidin by hemodialysis in pediatric and adult patients.
- The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage Kidney disease varies according to bone turnover: a potential role for PTH(7-...
- Ironing out the phosphorus problem.
- Circulating fibroblast growth factor 23 in patients with end-stage renal Disease treated by peritoneal dialysis is intact and biologically active.
- Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic Kidney disease.
- Chronic Kidney disease, hypovitaminosis D, and mortality in the United States.
- Hepcidin--a potential novel biomarker for iron status in chronic Kidney disease.
- Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal Failure on peritoneal dialysis.
- Technical approach to iliac crest biopsy.
- Lost in translation?
- Hypovitaminosis D in chronic Kidney disease.
- Intravenous paricalcitol for treatment of secondary Hyperparathyroidism in children on hemodialysis.
- Sevelamer controls parathyroid hormone-induced bone disease as efficiently as Calcium carbonate without increasing serum Calcium levels during therapy with active vita...
- Role of parathyroid hormone and therapy with active vitamin D sterols in Renal osteodystrophy.
- Calcification of the coronary arteries in the absence of atherosclerotic plaque.
- Special aspects of Renal osteodystrophy in children.
- Sudden blindness caused by anterior ischemic optic neuropathy in 5 children on continuous peritoneal dialysis.
- Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis.
- Outcome of slipped capital femoral epiphysis in Renal osteodystrophy.
- Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in Renal osteodystrophy.
- Clonal chromosomal defects in the molecular pathogenesis of refractory Hyperparathyroidism of uremia.
- Clinical research and training: an overview.
- PTH assays in renal Failure.
- Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients.
Schools
Universidad De Buenos Aires Facultad De Ciencias Medicas
Hospital Pd Pedro De Elizalde
Necker39s Hospital and Hospital Des Enfants Malady
UCLA Med Center
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Calcium Metabolism Disorders
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Pediatric Nephrology
Accepted Insurances
Awards
- Top Doctors:LA Area
- Top Doctors:Southern California
- Super Doctor
Education
-
UCLA Medical Center -
University of Buenos Aires
Hospital
-
Santa Monica-UCLA Medical Center and Orthopaedic Hospital -
Mattel Children's Hospital UCLA -
Ronald Reagan UCLA Medical Center
Drug Facts
| NPI NUMBER | 1861501546 | |
| NPPES Provider LastName | SALUSKY | |
| NPPES Provider FirstName | ISIDRO | |
| NPPES Provider ZIPCode | 900953075 | |
| NPPES Provider State | CA | |
| Specialty Description | Pediatric Medicine | |
| Total Claim Count | 238.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861501546 |
| Last Name Of The Provider | SALUSKY |
| First Name Of The Provider | ISIDRO |
| View All |
Similar Doctors
|
|
Dr. Mark R. Hanudel, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lynne S. Ticson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Beatriz D. Kuizon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dechu P. Puliyanda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel M. Lestz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert B. Ettenger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Omar N. Al-Masri, MD |
|
|
Dr. Gale L. Gordon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret Hsiau, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin V. Lemley, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gary R. Lerner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donna Elliott, MD |
|
|
Dr. Mohammad H. Malekzadeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence M. Opas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alfred J. Pennisi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eileen W. Tsai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ora Yadin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nadine M. Khouzam, MD |
|
|
Dr. Sabina S. Thyle, MD |
|
|
Dr. Emmanuelle R. Tiongson, MD |